Kozaci L D, Buttle D J, Hollander A P
University of Sheffield Medical School, UK.
Arthritis Rheum. 1997 Jan;40(1):164-74. doi: 10.1002/art.1780400121.
To determine the contribution of certain matrix metalloproteinases (MMPs) to the degradation of proteoglycan and type II collagen in cartilage.
Bovine nasal and articular cartilage explants were cultured with recombinant human interleukin-1 alpha (IL-1 alpha) for up to 4 weeks. Release of proteoglycan and type II collagen into the medium was determined by colorimetric assay and immunoassay, respectively. The activity of MMPs in the medium was assayed using a quenched fluorescent substrate, as well as with a collagen fibril assay, by zymography, and in Western immunoblots. In some experiments, the effects of specific MMP inhibitors on type II collagen degradation were studied.
In cultures of nasal cartilage with IL-1 alpha, almost all the proteoglycan was released within the first week, whereas there was no detectable release of type II collagen for the first 2 weeks of culture. A rapid period of almost complete dissolution of the collagen occurred in the third or fourth week. MMP activity measured using a quenched fluorescent substrate was negligible during the first 2 weeks of culture but was substantially increased in the third week of culture, at the time of collagen degradation. Similarly, there was a large increase in collagenolytic activity (by collagen fibril assay) and gelatinolytic activity (by zymography) during the third week of culture. Articular cartilage cultured with IL-1 alpha lost proteoglycan progressively during the 4-week period; however, there was no loss of type II collagen from the matrix in that time and no significant increase in MMP activity. The loss of type II collagen from nasal cartilage stimulated with IL-1 alpha was inhibited by BB87, an inhibitor of both collagenases and gelatinases, and by BB3003, a selective inhibitor of gelatinase A. In Western immunoblots, procollagenase and active interstitial collagenase could be readily detected in nasal cartilage cultures. Some procollagenase 3 and active collagenase 3 was also shown to be present.
MMP activity correlates with degradation of type II collagen, but not proteoglycan, in cartilage cultures. Interstitial collagenase, collagenase 3, and gelatinases are all likely to contribute to cleavage and removal of collagen from the cartilage matrix. The proteinase(s) responsible for aggrecan breakdown remains unclear.
确定某些基质金属蛋白酶(MMPs)对软骨中蛋白聚糖和Ⅱ型胶原降解的作用。
将牛鼻软骨和关节软骨外植体用重组人白细胞介素-1α(IL-1α)培养长达4周。分别通过比色法和免疫测定法测定蛋白聚糖和Ⅱ型胶原释放到培养基中的量。使用淬灭荧光底物以及通过胶原原纤维测定法、酶谱法和蛋白质免疫印迹法测定培养基中MMPs的活性。在一些实验中,研究了特异性MMP抑制剂对Ⅱ型胶原降解的影响。
在含有IL-1α的鼻软骨培养物中,几乎所有蛋白聚糖在第一周内释放,而在培养的前2周内未检测到Ⅱ型胶原的释放。在第三周或第四周出现了胶原几乎完全溶解的快速时期。使用淬灭荧光底物测定的MMP活性在培养的前2周内可忽略不计,但在培养的第三周,即胶原降解时大幅增加。同样,在培养的第三周,胶原溶解活性(通过胶原原纤维测定法)和明胶溶解活性(通过酶谱法)大幅增加。用IL-1α培养的关节软骨在4周内逐渐失去蛋白聚糖;然而,在此期间基质中Ⅱ型胶原没有损失,MMP活性也没有显著增加。BB87(一种胶原酶和明胶酶的抑制剂)和BB3003(一种明胶酶A的选择性抑制剂)可抑制IL-1α刺激的鼻软骨中Ⅱ型胶原的损失。在蛋白质免疫印迹中,可在鼻软骨培养物中轻易检测到前胶原酶和活性间质胶原酶。还显示存在一些前胶原酶3和活性胶原酶3。
在软骨培养物中,MMP活性与Ⅱ型胶原的降解相关,但与蛋白聚糖的降解无关。间质胶原酶、胶原酶3和明胶酶都可能有助于从软骨基质中切割和去除胶原。负责聚集蛋白聚糖分解的蛋白酶尚不清楚。